[{"id":"01e94ab7-1db7-466d-ba3b-41de1e68aa90","acronym":"PERCELLVAC","url":"https://clinicaltrials.gov/study/NCT02709616","created_at":"2022-05-27T22:55:26.156Z","updated_at":"2024-07-02T16:36:09.769Z","phase":"Phase 1","brief_title":"Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC)","source_id_and_acronym":"NCT02709616 - PERCELLVAC","lead_sponsor":"Guangdong 999 Brain Hospital","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e tumor antigen pulsed DC autologous cellular vaccine (personalized cellular vaccine)"],"overall_status":"Completed","enrollment":" Enrollment 10","initiation":"Initiation: 03/01/2016","start_date":" 03/01/2016","primary_txt":" Primary completion: 10/31/2017","primary_completion_date":" 10/31/2017","study_txt":" Completion: 06/30/2019","study_completion_date":" 06/30/2019","last_update_posted":"2022-05-27"},{"id":"9938eb41-5c2a-4e6d-a843-b0b50eb83959","acronym":"PerCellVac2","url":"https://clinicaltrials.gov/study/NCT02808364","created_at":"2022-05-27T22:55:35.734Z","updated_at":"2024-07-02T16:36:09.715Z","phase":"Phase 1","brief_title":"Personalized Cellular Vaccine for Recurrent Glioblastoma (PERCELLVAC2)","source_id_and_acronym":"NCT02808364 - PerCellVac2","lead_sponsor":"Guangdong 999 Brain Hospital","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e tumor antigen pulsed DC autologous cellular vaccine (personalized cellular vaccine)"],"overall_status":"Completed","enrollment":" Enrollment 10","initiation":"Initiation: 03/01/2016","start_date":" 03/01/2016","primary_txt":" Primary completion: 10/31/2017","primary_completion_date":" 10/31/2017","study_txt":" Completion: 06/30/2019","study_completion_date":" 06/30/2019","last_update_posted":"2022-05-27"},{"id":"e5237131-82f4-4978-a8ef-0a93b269c4a7","acronym":"PerCellVac3","url":"https://clinicaltrials.gov/study/NCT02808416","created_at":"2022-05-27T22:55:36.316Z","updated_at":"2024-07-02T16:36:09.773Z","phase":"Phase 1","brief_title":"Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3)","source_id_and_acronym":"NCT02808416 - PerCellVac3","lead_sponsor":"Guangdong 999 Brain Hospital","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e tumor antigen pulsed DC autologous cellular vaccine (personalized cellular vaccine)"],"overall_status":"Completed","enrollment":" Enrollment 10","initiation":"Initiation: 03/01/2016","start_date":" 03/01/2016","primary_txt":" Primary completion: 10/31/2017","primary_completion_date":" 10/31/2017","study_txt":" Completion: 06/30/2019","study_completion_date":" 06/30/2019","last_update_posted":"2022-05-27"}]